Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 40

1.

Prognostic value of circulating endothelial cells in metastatic colorectal cancer.

Rahbari NN, Schölch S, Bork U, Kahlert C, Schneider M, Rahbari M, Büchler MW, Weitz J, Reissfelder C.

Oncotarget. 2017 Jun 6;8(23):37491-37501. doi: 10.18632/oncotarget.16397.

2.

LDB1 overexpression is a negative prognostic factor in colorectal cancer.

García SA, Swiersy A, Radhakrishnan P, Branchi V, Kanth Nanduri L, Győrffy B, Betzler AM, Bork U, Kahlert C, Reißfelder C, Rahbari NN, Weitz J, Schölch S.

Oncotarget. 2016 Dec 20;7(51):84258-84270. doi: 10.18632/oncotarget.12481.

3.

Circulating tumor cells exhibit stem cell characteristics in an orthotopic mouse model of colorectal cancer.

Schölch S, García SA, Iwata N, Niemietz T, Betzler AM, Nanduri LK, Bork U, Kahlert C, Thepkaysone ML, Swiersy A, Büchler MW, Reissfelder C, Weitz J, Rahbari NN.

Oncotarget. 2016 May 10;7(19):27232-42. doi: 10.18632/oncotarget.8373.

4.

Improvement of neuronal cell survival by astrocyte-derived exosomes under hypoxic and ischemic conditions depends on prion protein.

Guitart K, Loers G, Buck F, Bork U, Schachner M, Kleene R.

Glia. 2016 Jun;64(6):896-910. doi: 10.1002/glia.22963. Epub 2016 Mar 16.

PMID:
26992135
5.

[Importance of preoperative and intraoperative imaging for operative strategies].

Nitschke P, Bork U, Plodeck V, Podlesek D, Sobottka SB, Schackert G, Weitz J, Kirsch M.

Chirurg. 2016 Mar;87(3):179-88. doi: 10.1007/s00104-016-0163-8. Review. German.

PMID:
26939896
6.

Top-down approach to the superior mesenteric artery and the mesopancreas during pancreatoduodenectomy for pancreatic cancer.

Welsch T, Bork U, Distler M, Weitz J.

J Surg Oncol. 2016 May;113(6):668-71. doi: 10.1002/jso.24204. Epub 2016 Feb 22.

PMID:
26898308
7.

[MBA - The Physician of Tomorrow?]

Bork U, Welsch T, Weitz J.

Klin Monbl Augenheilkd. 2015 Dec;232(12):e57-e67. doi: 10.1055/s-0033-1358213. Epub 2015 Dec 15. German.

PMID:
26669352
8.

Metastatic Spread Emerging From Liver Metastases of Colorectal Cancer: Does the Seed Leave the Soil Again?

Rahbari NN, Bork U, Schölch S, Reissfelder C, Thorlund K, Betzler A, Kahlert C, Schneider M, Ulrich AB, Büchler MW, Weitz J, Koch M.

Ann Surg. 2016 Feb;263(2):345-52. doi: 10.1097/SLA.0000000000001341.

PMID:
26501709
9.

Overexpression of SIX1 is an independent prognostic marker in stage I-III colorectal cancer.

Kahlert C, Lerbs T, Pecqueux M, Herpel E, Hoffmeister M, Jansen L, Brenner H, Chang-Claude J, Bläker H, Kloor M, Roth W, Pilarsky C, Rahbari NN, Schölch S, Bork U, Reissfelder C, Weitz J, Aust D, Koch M.

Int J Cancer. 2015 Nov 1;137(9):2104-13. doi: 10.1002/ijc.29596. Epub 2015 May 21.

10.

Circulating tumour cells and outcome in non-metastatic colorectal cancer: a prospective study.

Bork U, Rahbari NN, Schölch S, Reissfelder C, Kahlert C, Büchler MW, Weitz J, Koch M.

Br J Cancer. 2015 Apr 14;112(8):1306-13. doi: 10.1038/bjc.2015.88. Epub 2015 Mar 31.

11.

Radiotherapy combined with TLR7/8 activation induces strong immune responses against gastrointestinal tumors.

Schölch S, Rauber C, Tietz A, Rahbari NN, Bork U, Schmidt T, Kahlert C, Haberkorn U, Tomai MA, Lipson KE, Carretero R, Weitz J, Koch M, Huber PE.

Oncotarget. 2015 Mar 10;6(7):4663-76.

12.

Survival after renal cell carcinoma metastasis to the thyroid: single center experience and systematic review of the literature.

Beutner U, Leowardi C, Bork U, Lüthi C, Tarantino I, Pahernik S, Wente MN, Büchler MW, Schmied BM, Müller SA.

Thyroid. 2015 Mar;25(3):314-24. doi: 10.1089/thy.2014.0498. Epub 2015 Jan 14. Review.

PMID:
25491306
13.

Prognostic relevance of minimal residual disease in colorectal cancer.

Bork U, Grützmann R, Rahbari NN, Schölch S, Distler M, Reissfelder C, Koch M, Weitz J.

World J Gastroenterol. 2014 Aug 14;20(30):10296-304. doi: 10.3748/wjg.v20.i30.10296. Review.

14.

Immune escape and survival mechanisms in circulating tumor cells of colorectal cancer.

Steinert G, Schölch S, Niemietz T, Iwata N, García SA, Behrens B, Voigt A, Kloor M, Benner A, Bork U, Rahbari NN, Büchler MW, Stoecklein NH, Weitz J, Koch M.

Cancer Res. 2014 Mar 15;74(6):1694-704. doi: 10.1158/0008-5472.CAN-13-1885. Epub 2014 Mar 5.

15.

Chemotherapy-associated liver injury and its influence on outcome after resection of colorectal liver metastases.

Reissfelder C, Brand K, Sobiegalla J, Rahbari NN, Bork U, Schirmacher P, Büchler MW, Weitz J, Koch M.

Surgery. 2014 Feb;155(2):245-54. doi: 10.1016/j.surg.2013.07.022. Epub 2013 Dec 5.

PMID:
24314883
16.

Neoadjuvant radiotherapy for rectal cancer: meta-analysis of randomized controlled trials.

Rahbari NN, Elbers H, Askoxylakis V, Motschall E, Bork U, Büchler MW, Weitz J, Koch M.

Ann Surg Oncol. 2013 Dec;20(13):4169-82. doi: 10.1245/s10434-013-3198-9. Epub 2013 Sep 4.

PMID:
24002536
17.

Randomized clinical trial on the effect of coffee on postoperative ileus following elective colectomy.

Müller SA, Rahbari NN, Schneider F, Warschkow R, Simon T, von Frankenberg M, Bork U, Weitz J, Schmied BM, Büchler MW.

Br J Surg. 2012 Nov;99(11):1530-8. doi: 10.1002/bjs.8885. Epub 2012 Sep 14.

18.

AB0 blood group and prognosis in patients with pancreatic cancer.

Rahbari NN, Bork U, Hinz U, Leo A, Kirchberg J, Koch M, Büchler MW, Weitz J.

BMC Cancer. 2012 Jul 28;12:319. doi: 10.1186/1471-2407-12-319.

19.

Resection of the primary tumour versus no resection prior to systemic therapy in patients with colon cancer and synchronous unresectable metastases (UICC stage IV): SYNCHRONOUS--a randomised controlled multicentre trial (ISRCTN30964555).

Rahbari NN, Lordick F, Fink C, Bork U, Stange A, Jäger D, Luntz SP, Englert S, Rossion I, Koch M, Büchler MW, Kieser M, Weitz J; SYNCHRONOUS trial group.

BMC Cancer. 2012 Apr 5;12:142. doi: 10.1186/1471-2407-12-142.

20.

Supplemental Content

Support Center